Pharmaceutical & Biotech

Looking to de-risk your R&D or regulatory submission?

Reach out!
Pharmaceutical & Biotech Testing Services | Biobide CRO
Pharmaceutical & Biotech

De-risk hits selection and regulatory submissions

Non-clinical toxicity and efficacy supportive packages. Phase II GLP ERA packages.

88%DART sensitivity & accuracy
>80%genetic homology to humans
70+transgenic lines in-house

Selected clients in this space: NIH · MMV · DNDi

Relevant from the catalogue

Assays this industry books most

Regulatory context

Data is generated to sit ahead of ICH-aligned non-clinical safety packages, with genotoxicity follow-up strategies built directly around the ICH S2(R1) weight-of-evidence framework. GLP ERA packages for regulatory submissions.

Send us the series, not just the lead candidate

We scope a screening battery against your compound list and timeline, and assign a Study Director before the first plate is run.

clientes@biobide.com +34 943 309 360